Market Access

NICE says yes to Novartis’ multiple sclerosis therapy Kesimpta

https://pharmaphorum.com/news/nice-says-yes-to-novartis-multiple-sclerosis-therapy-kesimpta/

NICE unveils five year plan promising faster access to medicines

https://pharmaphorum.com/news/nice-unveils-five-year-plan-promising-faster-access-to-medicines/

EMA starts review of GSK/Vir COVID-19 antibody

https://pharmaphorum.com/news/ema-starts-review-of-gsk-vir-covid-19-antibody/

World Orphan Drug Congress USA Virtual 2021

https://pharmaphorum.com/events/world-orphan-drug-congress-usa-virtual-2021/

Three pillars of post-pandemic launch excellence

https://pharmaphorum.com/views-and-analysis/three-pillars-of-post-pandemic-launch-excellence/

https://pharmaphorum.com/news/nice-recommends-alexions-long-acting-ultomiris-for-pnh/

Czech Republic swoops for Denmark’s 2.4m unwanted AZ COVID shots

https://pharmaphorum.com/news/czech-republic-swoops-for-denmarks-2-4m-unwanted-az-covid-shots/

Global impact: How regulatory affairs is shaping development of cutting-edge pharma innovation

https://pharmaphorum.com/views-and-analysis/global-impact-how-regulatory-affairs-is-shaping-development-of-cutting-edge-pharma-innovation/

England begins Moderna vaccine rollout as lockdown eases

https://pharmaphorum.com/news/england-begins-moderna-vaccine-rollout-as-lockdown-eases/

1 2 3 4 5 >»

Close in 10 seconds

Pharmaphorum.com

Search